Literature DB >> 2546354

Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor.

T Yasuda1, G Sobue, T Mitsuma, A Takahashi, Y Hashizume.   

Abstract

In situ expression of nerve growth factor (NGF) receptors in human dermal and plexiform neurofibroma, schwannoma and traumatic neuroma was examined by an immunohistochemical method using a monoclonal anti-human NGF receptor antibody. Immunoreactivity for the NGF receptor was observed on the principal cells of both neurofibroma and schwannoma. Immunostaining by the anti-S-100 beta protein antibody in adjacent sections suggested that the vast majority of NGF receptor-positive cells were also positive for S-100 beta protein. In traumatic neuroma, staining for the NGF receptor was more intense in the perineurium than in the endoneurial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546354     DOI: 10.1007/BF00687886

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  43 in total

1.  Nerve growth factor receptors on cultured rat Schwann cells.

Authors:  P S DiStefano; E M Johnson
Journal:  J Neurosci       Date:  1988-01       Impact factor: 6.167

Review 2.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

Review 3.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

4.  Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells.

Authors:  K H Sonnenfeld; P Bernd; G Sobue; M Lebwohl; A E Rubenstein
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

5.  Serum neuronal growth factor levels in von Recklinghausen's neurofibromatosis.

Authors:  R J Riopelle; V M Riccardi; S Faulkner; M C Martin
Journal:  Ann Neurol       Date:  1984-07       Impact factor: 10.422

6.  Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Authors:  A H Ross; P Grob; M Bothwell; D E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; M Herlyn; B Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Increased levels of a nerve-growth-factor cross-reacting protein in "central" neurofibromatosis.

Authors:  R N Fabricant; G J Todaro; R Eldridge
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

8.  Peripheral nerve sheath tumors: an electron microscopic study of 43 cases.

Authors:  R A Erlandson; J M Woodruff
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

9.  Changes in the concentration of enolase isozymes and S-100 protein in degenerating and regenerating rat sciatic nerve.

Authors:  K Kato; T Satoh
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

10.  Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.

Authors:  E Kawahara; Y Oda; A Ooi; S Katsuda; I Nakanishi; S Umeda
Journal:  Am J Surg Pathol       Date:  1988-02       Impact factor: 6.394

View more
  3 in total

1.  Symmetrical neurofibroma with Schwann cell predominance and focal formation of microneurinomas.

Authors:  R Schober; G Reifenberger; G Kremer; H Urich
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Macromolecular permeability across the blood-nerve and blood-brain barriers.

Authors:  J F Poduslo; G L Curran; C T Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

3.  Sural nerve immunoreactivity for nerve growth factor receptor in a case of localized hypertrophic neuropathy.

Authors:  M Sciacco; E Scarpini; P L Baron; R Doronzo; M Moggio; D Passerini; G Scarlato
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.